Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Prostatic Neoplasms 3Pancreatic Neoplasms 2Neoplasms 2Gastrointestinal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Small Cell Lung Carcinoma 1Sarcoma 1Recurrence 1Pancreatic Cancer Resectable 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Estrogen Receptor Positive Breast Cancer 1Colorectal Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1COVID-19 1Breast Neoplasms, Male 1Breast Neoplasms 1Bone Metastases 1Biliary Tract Neoplasms 1Bile Duct Neoplasms 1Adenocarcinoma of Lung 1

Interventions

Oxaliplatin 3Irinotecan 3Surveys and Questionnaires 2Specimen Handling 2Radiosurgery 2Leucovorin 2Ketamine 2Hydroxychloroquine 2Fluorouracil 2Capecitabine 2ulixertinib 1tegafur-gimeracil-oteracil 1regorafenib 1pazopanib 1lanreotide 1fludarabine phosphate 1fludarabine 1dostarlimab 1dolasetron 1dexamethasone acetate 1dexamethasone 21-phosphate 1danvatirsen 1cobimetinib 1brivanib 1auricularum 1atezolizumab 1alectinib 1aldesleukin 1abelacimab 1Tomography, X-Ray Computed 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Gastrointestinal Neoplasms × Hydroxychloroquine × Clear all
NCT05221320 2025-09-25

Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) Malignancies

BioMed Valley Discoveries, Inc

Phase 2 Terminated
47 enrolled 18 charts
Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms

NCT04214418 2024-12-18

MEKiAUTO

Columbia University

Phase 1/2 Terminated
27 enrolled 12 charts
Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡